Riskpilot← Back to searchSign inGet full accessSOLØR DYREKLINIKK AS
ASActiveOrg 912079112Negardssvingen 2, 2270 FlisaVeterinary activities · NACE 7500Est. 201313 employees
Revenue 2024
NOK 8,4M
+3% vs 2023
EBITDA margin
2.8%
-40% vs 2023
Equity ratio
46.4%
Financial strength
Net profit 2024
NOK 136K
-52% vs 2023
| Revenue | NOK 8,4M | +3% |
| EBITDA | NOK 235K | -40% |
| Net profit | NOK 136K | -52% |
| Total assets | NOK 2,5M | +3% |
| Equity | NOK 1,2M | +3% |
| Employees | 13 | — |
Legal name
SOLØR DYREKLINIKK AS
Org number
912079112
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
17. juni 2013
Share capital
NOK 150 000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Å drive dyreklinikk med behandling av dyr og salg av for og tilhørende utstyr.
Address
Negardssvingen 2, 2270 Flisa
Phone
+4762951814
Email
post@solor-dyreklinikk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 822 | 8 608 | 8 061 | 8 158 | 8 410 |
| Staff expenses | −3 772 | −4 648 | −4 050 | −4 276 | −4 471 |
| EBITDA | 865 | 679 | 714 | 390 | 235 |
| Depreciation & amort. | −65 | −70 | −61 | −43 | −98 |
| EBIT | 800 | 609 | 654 | 346 | 138 |
| Net financials | 20 | 23 | 21 | 10 | 13 |
| Profit before tax | 820 | 633 | 674 | 357 | 150 |
| Tax | 180 | 132 | 147 | 74 | 15 |
| Net profit | 640 | 500 | 527 | 283 | 136 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 087 | 2 259 | 2 084 | 2 418 | 2 484 |
| Equity | 293 | 393 | 833 | 1 116 | 1 152 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 794 | 1 866 | 1 251 | 1 302 | 1 332 |
| Total debt | 1 794 | 1 866 | 1 251 | 1 302 | 1 332 |
EBITDA margin
2.8%
This company
15.8%
Market median
-82% vs market
20202024
Equity ratio
46.4%
This company
38.2%
Market median
+21% vs market
20202024
Return on equity
11.8%
This company
18.4%
Market median
+36% vs market
20202024
Net profit margin
1.6%
This company
8.1%
Market median
-80% vs market
20202024
Asset turnover
3.39×
This company
1.12×
Market median
+203% vs market
20202024
Debt / equity
1.16×
This company
0.62×
Market median
-87% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2022 | |
| Individual | 16.56% | 16.56% | 2022 | |
| Individual | 10% | 10% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SOLØR DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Andrea Ausen Engen | Board of Directors | 0 companies |
| Mari Vestmo Rolsdorph | Board of Directors | 0 companies |
| Ingunn Birkely | Chairman | 0 companies |
| Nina Haraldstad | Board of Directors | 0 companies |